International Medical Advertising Compliance for Indian Healthcare Brands: A Regulator-by-Regulator Guide
Indian healthcare brands targeting international patients operate under TWO regulatory layers: Indian rules (NMC, ART Act, NCISM, Drugs Act) and target-market rules (DHA, ASA, AHPRA, FTC, MOH). The intersection isn't obvious. Here's the guide.
No pitch. Written root-cause diagnosis. AI-powered, healthcare only.
Direct answer
Indian healthcare brands targeting international patients operate under TWO regulatory layers: Indian rules (NMC, ART Act, NCISM, Drugs Act) and target-market rules (DHA, ASA, AHPRA, FTC, MOH). The intersection isn't obvious. Here's the guide.
TL;DR
Indian healthcare brands targeting international patients operate under a regulatory regime that's more complex than purely Indian or purely international compliance. Two regulatory layers apply simultaneously: the Indian framework (NMC Code, Drugs & Magic Remedies Act, Schedule J, DCI, ART Act, NCISM, Telemedicine Practice Guidelines) governs what the Indian clinic can publish; the target-market regulator (DHA, CQC + ASA, AHPRA, FTC, MOH) governs what reaches the target patient.
When the two layers conflict, the stricter rule wins. Most Indian healthcare brands either don't know this or implement it inconsistently. This article is the regulator-by-regulator guide.
The two-layer principle
Every patient-facing piece of content must pass both Indian and target-market compliance review. ICG's content review process layers both reviews — and applies the stricter of the two on any contested claim. Specific guidance:
- If Indian rule prohibits and target rule permits → prohibited
- If target rule prohibits and Indian rule permits → prohibited
- If both permit → permitted with sourcing
- If both prohibit → obviously prohibited
The defensive position is always to apply the strictest applicable rule across all markets, accepting that this may produce more conservative content than competitors who only consider their own market's rules.
UAE — DHA (Dubai) / DOH (Abu Dhabi) / MOH (Federal)
Pre-approval requirement: For UAE-licensed clinics, yes. For Indian clinics targeting UAE patients, no — but the practical compliance bar still applies.
Permitted:
- Comparative cost statements with sourcing ("treatment in India costs ₹X; comparable UAE pricing AED Y" with public sourcing)
- Service description, credentialing, JCI/NABH accreditation visibility
- Patient testimonial videos (with strict consent)
- Doctor introduction content
- Visa + travel support guidance
Prohibited:
- Outcome guarantees ("guaranteed pregnancy with IVF")
- Success-rate claims (aligns with Indian ART Act + NMC)
- Drug names in patient-facing content (aligns with Indian Drugs & Magic Remedies Act)
- Misleading "UAE-based service" implications
- Comparative claims against named UAE providers
Required:
- Clear "Treatment performed at [Indian clinic name + city]" disclaimer
- JCI or equivalent international accreditation displayed if applicable
UK — CQC + ASA
CQC regulates UK-licensed healthcare providers. Not directly applicable to Indian clinics, but UK patients carry CQC-conditioned expectations.
ASA regulates advertising visible to UK consumers regardless of advertiser location. Indian clinic running Meta Ads visible in UK is bound by ASA rules.
Permitted:
- Cost transparency (strongly preferred by ASA)
- Service description
- Credential claims with substantiation
- Patient testimonial content (with strict consent and currency)
- Before-after imagery for non-surgical procedures (with strict consent)
Prohibited:
- Superlative claims ("best", "leading") without independently verifiable data
- Celebrity endorsements without paid-promotion disclosure
- Manipulated imagery (Photoshop, filters that alter outcome)
- Before-after imagery for surgical procedures (more restrictive than India)
- Misleading "from £X" pricing without context
Required:
- Clear UK ASA-compliant disclaimer if running paid ads in UK
- Cost transparency with full inclusions/exclusions
Australia — AHPRA
The Australian Health Practitioner Regulation Agency is among the strictest international healthcare regulators. AHPRA rules apply to any healthcare advertising visible to Australian consumers, regardless of practitioner location.
Permitted:
- Service description
- Credentialing
- Cost transparency (strongly required)
- Practitioner registration details
Prohibited (this is the strict part):
- Testimonials of any kind. This is the AHPRA-specific hard rule, stricter than India, UK, or USA. Patient testimonials are explicitly disallowed in AHPRA-visible advertising.
- Outcome claims
- Before-after images for surgical or cosmetic procedures
- Discounting or "limited time" offers
- Misleading "experience" claims without substantiation
Required:
- Practitioner registration details visible
- Clear cost transparency
- No testimonial content on any page that ranks for Australia-targeted queries
Implication for Indian clinics: Testimonial content must be removed from pages targeting Australian patients, even if testimonials are permitted in India. This often means maintaining separate page versions for Australia vs other markets.
USA — FTC + state medical boards
Meta Catalyst IQ 2-day comparative snapshot showing yesterday vs day-before performance with delta pills for a Meta Ads campaign" width="1200" height="675" loading="lazy" decoding="async" style="width:100%;height:auto;display:block;">US regulation is a patchwork. Federal Trade Commission Endorsement Guides + state-specific medical board rules apply.
Permitted:
- Cost transparency
- Service description
- Credentials with substantiation
- Patient stories with material connection disclosure
- Before-after content with consent (state rules vary)
Prohibited:
- "FDA-approved" or "clinically proven" without specific evidence
- Influencer / patient-story content without material connection disclosure (FTC)
- Misleading "guaranteed" or "100%" claims
- State-specific rules around physician advertising (California, New York, Texas have additional layers)
Required:
- Material connection disclosure on influencer / patient-story content (FTC)
- HIPAA-aligned data handling for US patient data
- State-specific compliance for ads targeting California / New York / Texas
Singapore — MOH Private Hospitals & Medical Clinics Act
Singapore's framework is closer to UAE's. Conservative content rules for Indian clinics targeting Singapore patients.
Permitted:
- Service description
- Credentialing visibility
- Cost transparency (strongly required)
- Doctor introduction content
Prohibited:
- Outcome claims
- Comparative claims
- Misleading "Singapore-based service" implications
Required:
- Clear "treatment in India" disclaimer
- Doctor credentials visible
- PDPA-aligned data handling for Singapore patient data
Canada — CMA + provincial medical regulators
Provincial variation is significant. Conservative defaults apply.
Permitted:
- Service description
- Cost transparency
- Credentials with substantiation
Prohibited:
- Comparative outcome claims
- Misleading provincial-specific claims
- Province-specific rules vary (Ontario CPSO, BC College, Quebec CMQ)
Bangladesh + Nepal — BMDC + NMC Nepal
Conservative framing for proximity markets. Generally aligned with Indian NMC standards.
How ICG implements multi-regulator compliance
Across HealthApex OS engagements:
- Content review process layers Indian + target-market rules
- Pages tagged with applicable regulator set
- Stricter-rule application across all contested claims
- Audit before publication on every international-facing page
- Quarterly compliance review for any rule updates
- Audit trail retained for 7 years per DPDP + regulatory requirements
ICG operates with zero formal compliance complaints across 150+ healthcare client engagements since 2018 — a record we maintain through systematic two-layer review, not aggressive marketing positioning.
Related reads
- International SEO Agency India — pillar
- How to get international patients 2026
- Medical Tourism Marketing India
- Client Alleviation Programme — includes compliance training for team
Book a free 30-minute Brand & Growth Diagnostic.
It's a working session, not a sales pitch — you leave with a written root-cause analysis you can act on, whether or not you engage ICG.
Questions readers ask
about this topic.
The three platforms
behind every ICG engagement.
Beacon
CAPI middleware that fixes Event Match Quality, translates CRM statuses to Meta-standard events, dedups across channels.
Agency OS
Live client dashboard. GSC, GA4, Google Ads, Meta Ads, IVR calls in one view. Login anytime, not monthly.
Phoenix
Clinic revenue intelligence over your PMS. Daily action queue: Prevent Loss, Maintain & Engage, Grow Revenue. 46-centre rollout.
Or book a free 30-min audit to see all three in action on your account.
Healthcare brands
that already run on ICG.
A representative slice of the 150+ healthcare brands ICG has delivered for across India. Most engagements remain under NDA.
What ICG clients say · on video.
"Scale up of organic channels and business consulting. ICG has absolute domain authority in their field."
"Working with ICG transformed how we acquire IVF patients in Gurgaon. They understand the fertility journey from inquiry to consult..."
"What Ichelon accomplished — they got all my ideas and worked over 3-4 months to create an amazing, super-customised website."
Need help operationalising this?
Every ICG service is healthcare-only, NMC + DPDP-aware, and built around the patient-research patterns that drive Indian healthcare growth in 2026.
More from
ICG.
Healthcare AIO is the discipline of getting your clinic or hospital cited inside Google AI Overviews, ChatGPT and Perplexity answers — not j...
Conversational-search advertising places brand messages inside AI chat answers — ChatGPT, Perplexity, Copilot — rather than beside a results...
NABH digital compliance means every claim, image and testimonial your hospital publishes online matches what an accreditation surveyor can v...
Stop guessing.
Book a Diagnostic.
30 minutes. Free. With the AI-powered healthcare-only marketing agency 150+ brands already run on. No slides, no pitch, no hard close.
